New drug interaction study launches for elecoglipron and statins
NCT ID NCT07534592
First seen Apr 20, 2026 · Last updated Apr 30, 2026 · Updated 2 times
Summary
This early-stage study will look at how a new drug called elecoglipron changes the way the body processes two common cholesterol-lowering medications (atorvastatin and rosuvastatin). About 40 healthy volunteers will take the drugs in a fixed order, and researchers will measure drug levels in the blood. The goal is to understand if elecoglipron affects how these statins work, which is important for future safe use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
Glendale, California, 91206, United States
-
Research Site
Brooklyn, Maryland, 21225, United States
Conditions
Explore the condition pages connected to this study.